Baijin Life Science HoldingsMNNGF 26 PS Ratio is 5.77 as of Jul. 06, 2026, which is 44% above its 10-year median of 4.00. GuruFocus rates MNNGF with a GF Score™ of 26/100 and a GF Value™ of $0.06. The stock has 4 warning signs investors should review. Among 1,113 Retail - Cyclical companies, Baijin Life Science Holdings ranks worse than 96.5% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Baijin Life Science Holdings's share price is $0.075.
Baijin Life Science Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2025 was $0.01. Hence, Baijin Life Science Holdings's PS Ratio for today is 5.77.
The historical rank and industry rank for Baijin Life Science Holdings's PS Ratio or its related term are showing as below:
MNNGF'
s PS Ratio Range Over the Past 10 Years
Min: 0.19 Med: 4 Max: 13.47
Current: 9.59
During the past 13 years, Baijin Life Science Holdings's highest PS Ratio was 13.47. The lowest was 0.19. And the median was 4.00.
MNNGF's PS Ratio is ranked worse than 96.5% of 1113
companies
in the Retail - Cyclical industry
Industry Median: 0.64
vs MNNGF: 9.59
Baijin Life Science Holdings Ltd revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Baijin Life Science Holdings was -0.70% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 3.30% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -20.30% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -27.10% per year.
During the past 13 years, Baijin Life Science Holdings's highest 3-Year average Revenue per Share Growth Rate was 3.30% per year. The lowest was -45.20% per year. And the median was -21.90% per year.
Back to Basics: PS Ratio
Baijin Life Science Holdings (OTCPK:MNNGF) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Baijin Life Science Holdings PS Ratio Related Terms
Baijin Life Science Holdings PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Luxury Goods subindustry, Baijin Life Science Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baijin Life Science Holdings PS Ratio vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Baijin Life Science Holdings's PS Ratio distribution charts can be found below:
* The bar in red indicates where Baijin Life Science Holdings's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Baijin Life Science Holdings's Share Price of today is $0.075.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Baijin Life Science Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2025 was $0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Baijin Life Science Holdings (MNNGF) has a PS Ratio of 5.77 as of Jul. 06, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Baijin Life Science Holdings and its competitors. This is 44% above median its historical median of 4.00. Over the past decade, Baijin Life Science Holdings' PS Ratio has ranged from 0.19 to 13.47. According to the industry distribution chart, Baijin Life Science Holdings ranks #1074 out of 1113 companies in the Retail - Cyclical industry, placing it in the top 96.5%.
Is Baijin Life Science Holdings' PS Ratio too high?
Baijin Life Science Holdings' current PS Ratio of 5.77 is 44% above median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 0.19 to a high of 13.47. The Retail - Cyclical industry median PS Ratio is 0.64. Baijin Life Science Holdings' value of 5.77 is 801.6% above this industry median. Based on the distribution chart, Baijin Life Science Holdings ranks #1074 out of 1113 companies in the Retail - Cyclical industry, which is in the bottom quartile relative to peers. Overall, Baijin Life Science Holdings has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Baijin Life Science Holdings' PS Ratio compare to TPR?
According to the Retail - Cyclical industry distribution chart, Baijin Life Science Holdings ranks #1074 out of 1113 companies for PS Ratio. This places Baijin Life Science Holdings in the lower half of its industry. The industry median PS Ratio is 0.64. Baijin Life Science Holdings' value of 5.77 is 801.6% above this benchmark. Historically, Baijin Life Science Holdings' own PS Ratio has ranged from 0.19 to 13.47 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 0.64, Baijin Life Science Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Retail - Cyclical company?
The median PS Ratio among Retail - Cyclical companies is 0.64, based on 1,113 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Baijin Life Science Holdings's current PS Ratio of 5.77 is 801.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Baijin Life Science Holdings and its competitors. For the Retail - Cyclical industry, the median PS Ratio is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Baijin Life Science Holdings's current PS Ratio is 5.77, which is 44% above median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baijin Life Science Holdings stock overvalued right now?
Baijin Life Science Holdings (MNNGF) has a current PS Ratio of 5.77. The stock's GF Value™ is $0.06, compared to a current price of $0.08 — trading 25% above its estimated fair value. The current PS Ratio is 5.77, which is 44% above median its 10-year median of 4.00 and 801.6% above the Retail - Cyclical industry median of 0.64. Baijin Life Science Holdings' overall GF Score™ is 26/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Baijin Life Science Holdings (MNNGF), the current PS Ratio is 5.77 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Baijin Life Science Holdings (MNNGF) Overvalued in 2026?
Based on GuruFocus' analysis, Baijin Life Science Holdings stock appears to be overvalued.
The current stock price of $0.08 is trading 25% above its estimated GF Value™ of $0.06.
Key valuation signals for MNNGF:
PS Ratio: 5.77 (44% above median its 10-year median of 4.00)
GF Value™: $0.06 vs. price of $0.08 (25% above fair value)
Industry Position: 801.6% above the Retail - Cyclical median (#1074 of 1113)
No single metric tells the full story. See the MNNGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewelry business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewelry business segment.
26GF Score
Get the complete analysis for MNNGF
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MNNGF has been successfully added to your 
